Retatrutide is a cutting-edge peptide designed to support metabolic health, weight management, and energy balance. As a novel multi-agonist compound, it acts on GLP-1, GIP, and glucagon receptors — three key pathways that regulate appetite, glucose metabolism, and fat utilization. By targeting these

FOX04-DRI is a synthetic peptide fragment designed to selectively induce apoptosis in senescent (“zombie”) cells — dysfunctional cells that accumulate with age and contribute to inflammation, fatigue, and degenerative decline. By disrupting the interaction between FOXO4 and p53 pathways, FOX04-DRI

SS-31, also known as Elamipretide, is a mitochondrial-targeted peptide studied for its ability to protect and repair mitochondrial membranes. By binding to cardiolipin, a key mitochondrial lipid, SS-31 helps improve cellular energy production, reduce oxidative stress, and enhance cellular resilience

Survodutide is a novel multi-agonist peptide targeting both GLP-1 and glucagon receptors, designed to support powerful metabolic regulation, weight reduction, and improved energy balance. Its dual-pathway activation promotes appetite control while enhancing fat oxidation and metabolic output. Early

Follistatin is a powerful myostatin-binding protein studied for its ability to influence muscle growth, regeneration, and cellular repair. By blocking myostatin — the molecule that restricts muscle development — Follistatin may significantly enhance lean mass, strength, and functional performance

KLOW is a specialized peptide or peptide-blend formulation designed to support metabolic health, energy balance, and cellular optimization. Its exact mechanism varies by research focus, but it is commonly studied for enhancing vitality, improving recovery, and supporting healthy body composition. Early

AICAR (5-Aminoimidazole-4-carboxamide ribonucleotide) is a research peptide known for its ability to activate AMPK — the body’s master energy sensor. By stimulating AMPK activity, AICAR helps enhance endurance, promote fat utilization, and support cellular energy metabolism. Studies suggest that

Cagrilintide is a long-acting amylin analog studied for its effects on appetite regulation, weight reduction, and improved metabolic balance. As an amylin-based peptide, it works alongside GLP-1 pathways to reduce hunger, slow gastric emptying, and promote sustained caloric control. Research suggests

Tirzepatide is a dual GIP and GLP-1 receptor agonist studied for its powerful effects on weight reduction, metabolic control, and appetite regulation. By activating both incretin pathways, it supports improved insulin sensitivity, enhanced fat metabolism, and reduced hunger. Research shows Tirzepatide

IGF-1 LR3 (Insulin-Like Growth Factor-1 Long Arg3) is a potent, long-acting analog of IGF-1 designed to enhance muscle growth, support cellular repair, and promote nutrient uptake. With an extended half-life and improved receptor binding, IGF-1 LR3 is widely studied for its ability to drive anabolic

Adipotide is an innovative research peptide designed to selectively target and reduce white adipose tissue (WAT). It functions by binding to prohibitin receptors on the blood vessels that supply fat cells, disrupting their nutrient pathways and triggering apoptosis (programmed cell death).This mechanism

GLOW is a cosmetic and rejuvenation-focused peptide blend designed to support healthier, more youthful-looking skin. This peptide complex is studied for its ability to promote collagen production, reduce fine lines, improve hydration, and enhance overall skin radiance. Research suggests GLOW may support